8-K 1 f92466e8vk.htm CURRENT REPORT Form 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2003

QUESTCOR PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)
         
California   0-20772   33-0476164
(State or Other Jurisdiction   (Commission File Number)   (I.R.S. Employer Identification No.)
of Incorporation)        
     
3260 Whipple Road, Union City, California   94587
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (510) 400-0700

 

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Item 12. Results of Operations and Financial Condition.
SIGNATURE
Exhibit 99.1

Table of Contents

     This Current Report on Form 8-K is furnished by Questcor Pharmaceuticals, Inc., a California corporation (“Questcor” or the “Company”), in connection with the matters described herein.

Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.

     (a)      Not Applicable.

     (b)      Not Applicable.

     (c)      Exhibits.

  99.1   Press release furnished by Questcor Pharmaceuticals, Inc. dated August 14, 2003, relating to the Company’s results for the quarter ended June 30, 2003, referred to in Item 12 below.

Item 12.   Results of Operations and Financial Condition.

On August 14, 2003, the Company announced via press release its results for the quarter ended June 30, 2003. A copy of the Company’s press release is attached hereto as Exhibit 99.1. This Form 8-K and the attached exhibit are provided under Item 12 of Form 8-K and are furnished to, but not filed with, the Securities and Exchange Commission.

 

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
Date: August 14, 2003 QUESTCOR PHARMACEUTICALS, INC.
 
 
  By:   /s/ TIMOTHY E. MORRIS
     
 
      Timothy E. Morris
      Chief Financial Officer